Salix Pharmaceuticals Ltd (SLXP) Tops Q2 EPS by 6c, Guides Q3 Rev In-Line
Tweet Send to a Friend
Salix Pharmaceuticals Ltd (NASDAQ: SLXP) reported Q2 EPS of $0.87, $0.06 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
